Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 8,493,321 | 8,493,321 | 0 | $714.88M | $1.13B | 34.18% | +$412.44M |
| Oruka Therapeutics, Inc.(ORKA) | 4,148,428 | 4,148,428 | 0 | $203.48M | $394.81M | 11.97% | +$191.33M |
| Erasca, Inc.(ERAS) | 16,382,812 | 17,891,812 | +1,509,000 | $265.07M | $327.78M | 9.94% | +$62.70M |
| Spyre Therapeutics, Inc.(SYRE) | 3,685,448 | 2,985,448 | -700,000 | $185.89M | $265.05M | 8.04% | +$79.15M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,180,000 | 1,180,000 | 0 | $99.03M | $115.03M | 3.49% | +$16.00M |
| Ocular Therapeutix, Inc.(OCUL) | 10,346,926 | 10,346,926 | 0 | $87.64M | $101.61M | 3.08% | +$13.97M |
| Damora Therapeutics, Inc.(DMRA) | 3,603,595 | 3,603,595 | 0 | $93.33M | $93.73M | 2.84% | +$396.4K |
| Savara Inc.(SVRA) | 13,740,375 | 14,745,943 | +1,005,568 | $75.02M | $90.84M | 2.75% | +$15.81M |
| Jade Biosciences Inc | 3,220,364 | 3,220,364 | 0 | $45.25M | $71.56M | 2.17% | +$26.31M |
| Cogent Biosciences, Inc.(COGT) | 2,000,000 | 1,642,166 | -357,834 | $76.98M | $63.55M | 1.93% | -$13.43M |
| Viridian Therapeutics, Inc.(VRDN) | 3,882,709 | 3,257,917 | -624,792 | $75.95M | $59.85M | 1.81% | -$16.10M |
| Vor Biopharma Inc.(VOR) | 3,041,719 | 3,041,719 | 0 | $54.26M | $56.00M | 1.70% | +$1.73M |
| Dyne Therapeutics, Inc.(DYN) | 2,173,913 | 2,173,913 | 0 | $39.41M | $48.28M | 1.46% | +$8.87M |
| Maze Therapeutics, Inc.(MAZE) | 1,602,034 | 1,602,034 | 0 | $47.82M | $47.80M | 1.45% | -$16.0K |
| Relmada Therapeutics, Inc.(RLMD) | 4,843,380 | 6,844,305 | +2,000,925 | $33.71M | $47.36M | 1.44% | +$13.65M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,319,765 | 4,319,765 | 0 | $54.73M | $46.78M | 1.42% | -$7.95M |
| Crescent Biopharma, Inc.(CBIO) | 2,133,576 | 2,133,576 | 0 | $39.19M | $38.40M | 1.16% | -$789.4K |
| Zura Bio LimitedCL A(ZURA) | 6,434,990 | 6,434,990 | 0 | $38.29M | $37.97M | 1.15% | -$321.8K |
| Adlai Nortye Group Ltd.ADS(ANL) | 3,212,731 | 3,212,731 | 0 | $22.23M | $36.95M | 1.12% | +$14.71M |
| Enliven Therapeutics Inc | 1,726,331 | 526,331 | -1,200,000 | $67.67M | $26.71M | 0.81% | -$40.96M |
| Cybin D/B/A Helus Pharma(HELP) | 3,851,654 | 3,851,654 | 0 | $18.49M | $25.46M | 0.77% | +$6.97M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,379,965 | 1,379,965 | 0 | $19.61M | $25.13M | 0.76% | +$5.52M |
| Century Therapeutics, Inc.(IPSC) | 8,695,652 | 8,695,652 | 0 | $19.65M | $21.30M | 0.65% | +$1.65M |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,609,569 | 2,043,596 | +434,027 | $10.37M | $19.82M | 0.60% | +$9.46M |
| CytomX Therapeutics, Inc.(CTMX) | 9,982,124 | 4,982,124 | -5,000,000 | $46.92M | $18.68M | 0.57% | -$28.23M |
| Achieve Life Science Inc | 0 | 2,751,032 | +2,751,032 | $0 | $17.96M | 0.54% | +$17.96M |
| Parabilis Medicines Inc | 0 | 625,000 | +625,000 | $0 | $17.11M | 0.52% | +$17.11M |
| Surrozen, Inc.(SRZN) | 632,931 | 632,931 | 0 | $18.44M | $16.42M | 0.50% | -$2.01M |
| Korro Bio, Inc.(KRRO) | 1,009,500 | 1,009,500 | 0 | $11.43M | $13.31M | 0.40% | +$1.88M |
| Alto Neuroscience, Inc.(ANRO) | 500,000 | 500,000 | 0 | $11.24M | $13.20M | 0.40% | +$1.96M |
| X4 Pharmaceuticals, Inc.(XFOR) | 330,525 | 1,934,253 | +1,603,728 | $1.37M | $9.03M | 0.27% | +$7.67M |
| Research Alliance Corp IiiCL A | 0 | 300,000 | +300,000 | $0 | $3.21M | 0.10% | +$3.21M |
| InMed Pharmaceuticals Inc.(INM) | 0 | 32,685 | +32,685 | $0 | $50.7K | 0.00% | +$50.7K |
| Engene Holdings Inc COM | 4,771,414 | 0 | -4,771,414 | $32.49M | $0 | — | -$32.49M |
| Kalvista Pharmaceuticals Inc | 6,474,485 | 0 | -6,474,485 | $130.33M | $0 | — | -$130.33M |
| Septerna, Inc.(SEPN) | 506,056 | 0 | -506,056 | $12.16M | $0 | — | -$12.16M |
| Tenax Therapeutics, Inc.(TENX) | 1,675,262 | 0 | -1,675,262 | $26.79M | $0 | — | -$26.79M |